Published in J Bacteriol on March 01, 1996
A new evolutionary scenario for the Mycobacterium tuberculosis complex. Proc Natl Acad Sci U S A (2002) 13.50
Genetic requirements for mycobacterial survival during infection. Proc Natl Acad Sci U S A (2003) 9.15
Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains. J Bacteriol (2002) 8.88
Evolutionary relationships among diverse bacteriophages and prophages: all the world's a phage. Proc Natl Acad Sci U S A (1999) 7.05
Evolutionary genomics of Staphylococcus aureus: insights into the origin of methicillin-resistant strains and the toxic shock syndrome epidemic. Proc Natl Acad Sci U S A (2001) 6.22
The primary mechanism of attenuation of bacillus Calmette-Guerin is a loss of secreted lytic function required for invasion of lung interstitial tissue. Proc Natl Acad Sci U S A (2003) 5.83
Deletion of RD1 from Mycobacterium tuberculosis mimics bacille Calmette-Guérin attenuation. J Infect Dis (2002) 5.15
In vitro site-specific integration of bacteriophage DNA catalyzed by a recombinase of the resolvase/invertase family. Proc Natl Acad Sci U S A (1998) 5.04
Acute infection and macrophage subversion by Mycobacterium tuberculosis require a specialized secretion system. Proc Natl Acad Sci U S A (2003) 4.64
Individual RD1-region genes are required for export of ESAT-6/CFP-10 and for virulence of Mycobacterium tuberculosis. Mol Microbiol (2004) 4.62
Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence. Clin Microbiol Rev (2003) 4.14
Genome plasticity of BCG and impact on vaccine efficacy. Proc Natl Acad Sci U S A (2007) 3.73
Laboratory diagnosis of tuberculosis in resource-poor countries: challenges and opportunities. Clin Microbiol Rev (2011) 3.63
A recombinant Mycobacterium smegmatis induces potent bactericidal immunity against Mycobacterium tuberculosis. Nat Med (2011) 3.60
The ESAT-6 gene cluster of Mycobacterium tuberculosis and other high G+C Gram-positive bacteria. Genome Biol (2001) 3.58
Attenuation of and protection induced by a leucine auxotroph of Mycobacterium tuberculosis. Infect Immun (2000) 3.39
Rapid and simple approach for identification of Mycobacterium tuberculosis complex isolates by PCR-based genomic deletion analysis. J Clin Microbiol (2002) 3.32
Mutually dependent secretion of proteins required for mycobacterial virulence. Proc Natl Acad Sci U S A (2005) 3.29
Comparative evaluation of low-molecular-mass proteins from Mycobacterium tuberculosis identifies members of the ESAT-6 family as immunodominant T-cell antigens. Infect Immun (2000) 3.24
Tuberculous granuloma formation is enhanced by a mycobacterium virulence determinant. PLoS Biol (2004) 3.12
Diagnosis of tuberculosis based on the two specific antigens ESAT-6 and CFP10. Clin Diagn Lab Immunol (2000) 3.03
Detection of bacterial virulence genes by subtractive hybridization: identification of capsular polysaccharide of Burkholderia pseudomallei as a major virulence determinant. Infect Immun (2001) 2.76
Secreted transcription factor controls Mycobacterium tuberculosis virulence. Nature (2008) 2.71
Persistence and protective efficacy of a Mycobacterium tuberculosis auxotroph vaccine. Infect Immun (1999) 2.70
Extracellular M. tuberculosis DNA targets bacteria for autophagy by activating the host DNA-sensing pathway. Cell (2012) 2.65
Mycobacterium avium in the postgenomic era. Clin Microbiol Rev (2007) 2.65
PCR identification of Mycobacterium bovis BCG. J Clin Microbiol (1997) 2.60
Dissection of ESAT-6 system 1 of Mycobacterium tuberculosis and impact on immunogenicity and virulence. Infect Immun (2006) 2.56
Detection of deleted genomic DNA using a semiautomated computational analysis of GeneChip data. Genome Res (2000) 2.46
Gamma interferon release assays for detection of Mycobacterium tuberculosis infection. Clin Microbiol Rev (2014) 2.43
EsxA and EsxB are secreted by an ESAT-6-like system that is required for the pathogenesis of Staphylococcus aureus infections. Proc Natl Acad Sci U S A (2005) 2.42
Phagosomal rupture by Mycobacterium tuberculosis results in toxicity and host cell death. PLoS Pathog (2012) 2.39
ESAT-6 from Mycobacterium tuberculosis dissociates from its putative chaperone CFP-10 under acidic conditions and exhibits membrane-lysing activity. J Bacteriol (2007) 2.31
Structure and function of the complex formed by the tuberculosis virulence factors CFP-10 and ESAT-6. EMBO J (2005) 2.30
Antigenic equivalence of human T-cell responses to Mycobacterium tuberculosis-specific RD1-encoded protein antigens ESAT-6 and culture filtrate protein 10 and to mixtures of synthetic peptides. Infect Immun (2000) 2.29
Characterization of auxotrophic mutants of Mycobacterium tuberculosis and their potential as vaccine candidates. Infect Immun (2001) 2.21
Use of a novel approach, termed island probing, identifies the Shigella flexneri she pathogenicity island which encodes a homolog of the immunoglobulin A protease-like family of proteins. Infect Immun (1997) 2.17
The genome-sequenced variant of Campylobacter jejuni NCTC 11168 and the original clonal clinical isolate differ markedly in colonization, gene expression, and virulence-associated phenotypes. J Bacteriol (2004) 2.14
Protein analysis by shotgun/bottom-up proteomics. Chem Rev (2013) 2.13
Genetic basis of virulence attenuation revealed by comparative genomic analysis of Mycobacterium tuberculosis strain H37Ra versus H37Rv. PLoS One (2008) 2.01
Genomic analysis distinguishes Mycobacterium africanum. J Clin Microbiol (2004) 2.01
A genetic screen for Mycobacterium tuberculosis mutants defective for phagosome maturation arrest identifies components of the ESX-1 secretion system. Infect Immun (2007) 1.98
Systematic genetic nomenclature for type VII secretion systems. PLoS Pathog (2009) 1.96
Mapping of IS6110 insertion sites in two epidemic strains of Mycobacterium tuberculosis. J Clin Microbiol (2000) 1.95
Control of M. tuberculosis ESAT-6 secretion and specific T cell recognition by PhoP. PLoS Pathog (2008) 1.94
Bioluminescence screening in vitro (Bio-Siv) assays for high-volume antimycobacterial drug discovery. Antimicrob Agents Chemother (1996) 1.94
Sensitivity of a new commercial enzyme-linked immunospot assay (T SPOT-TB) for diagnosis of tuberculosis in clinical practice. Eur J Clin Microbiol Infect Dis (2005) 1.87
Hypoxic response of Mycobacterium tuberculosis studied by metabolic labeling and proteome analysis of cellular and extracellular proteins. J Bacteriol (2002) 1.86
Identification of a genomic island present in the majority of pathogenic isolates of Pseudomonas aeruginosa. J Bacteriol (2001) 1.85
Specific differentiation between Mycobacterium bovis BCG and virulent strains of the Mycobacterium tuberculosis complex. J Clin Microbiol (1998) 1.84
Analysis of the genetic differences between Neisseria meningitidis and Neisseria gonorrhoeae: two closely related bacteria expressing two different pathogenicities. Proc Natl Acad Sci U S A (1996) 1.83
The RD1 virulence locus of Mycobacterium tuberculosis regulates DNA transfer in Mycobacterium smegmatis. Proc Natl Acad Sci U S A (2004) 1.82
Specific T-cell epitopes for immunoassay-based diagnosis of Mycobacterium tuberculosis infection. J Clin Microbiol (2004) 1.81
Persistently elevated T cell interferon-gamma responses after treatment for latent tuberculosis infection among health care workers in India: a preliminary report. J Occup Med Toxicol (2006) 1.76
Genome scale comparison of Mycobacterium avium subsp. paratuberculosis with Mycobacterium avium subsp. avium reveals potential diagnostic sequences. J Clin Microbiol (2002) 1.73
Increased numbers of ESAT-6- and purified protein derivative-specific gamma interferon-producing cells in subclinical and active tuberculosis infection. Infect Immun (2000) 1.67
Genomics and the evolution, pathogenesis, and diagnosis of tuberculosis. J Clin Invest (2007) 1.66
Identification of novel Mycobacterium tuberculosis antigens with potential as diagnostic reagents or subunit vaccine candidates by comparative genomics. Infect Immun (2002) 1.66
PPE protein (Rv3873) from DNA segment RD1 of Mycobacterium tuberculosis: strong recognition of both specific T-cell epitopes and epitopes conserved within the PPE family. Infect Immun (2003) 1.66
Molecular and immunological characterization of Mycobacterium tuberculosis CFP-10, an immunodiagnostic antigen missing in Mycobacterium bovis BCG. J Clin Microbiol (2000) 1.66
Comparative genomics uncovers large tandem chromosomal duplications in Mycobacterium bovis BCG Pasteur. Yeast (2000) 1.65
Cellular immune responses to ESAT-6 discriminate between patients with pulmonary disease due to Mycobacterium avium complex and those with pulmonary disease due to Mycobacterium tuberculosis. Clin Diagn Lab Immunol (1999) 1.65
The specialized secretory apparatus ESX-1 is essential for DNA transfer in Mycobacterium smegmatis. Mol Microbiol (2008) 1.61
Delayed-type hypersensitivity responses to ESAT-6 and MPT64 from Mycobacterium tuberculosis in the guinea pig. Infect Immun (1998) 1.61
Mycobacterium tuberculosis triggers host type I IFN signaling to regulate IL-1β production in human macrophages. J Immunol (2011) 1.58
Identification of virulence genes in a pathogenic strain of Pseudomonas aeruginosa by representational difference analysis. J Bacteriol (2002) 1.58
The nature and consequence of genetic variability within Mycobacterium tuberculosis. J Clin Invest (2001) 1.58
Effect of helminth-induced immunity on infections with microbial pathogens. Nat Immunol (2013) 1.55
Bacterial artificial chromosome-based comparative genomic analysis identifies Mycobacterium microti as a natural ESAT-6 deletion mutant. Infect Immun (2002) 1.54
MTSA-10, the product of the Rv3874 gene of Mycobacterium tuberculosis, elicits tuberculosis-specific, delayed-type hypersensitivity in guinea pigs. Infect Immun (2000) 1.54
Molecular basis of intrinsic macrolide resistance in the Mycobacterium tuberculosis complex. Antimicrob Agents Chemother (2004) 1.47
Tuberculin skin testing compared with T-cell responses to Mycobacterium tuberculosis-specific and nonspecific antigens for detection of latent infection in persons with recent tuberculosis contact. Clin Diagn Lab Immunol (2001) 1.45
Evaluation of QuantiFERON-TB gold in-tube and tuberculin skin tests among immigrant children being screened for latent tuberculosis infection. Pediatr Infect Dis J (2015) 1.45
Genomic analysis of a mycobacterium bovis bacillus [corrected] Calmette-Guérin strain isolated from an adult patient with pulmonary tuberculosis.. PLoS One (2015) 1.43
Long-term protection against tuberculosis following vaccination with a severely attenuated double lysine and pantothenate auxotroph of Mycobacterium tuberculosis. Infect Immun (2005) 1.42
Attenuation of late-stage disease in mice infected by the Mycobacterium tuberculosis mutant lacking the SigF alternate sigma factor and identification of SigF-dependent genes by microarray analysis. Infect Immun (2004) 1.41
Revisiting the evolution of Mycobacterium bovis. J Bacteriol (2005) 1.39
Two-dimensional electrophoresis for analysis of Mycobacterium tuberculosis culture filtrate and purification and characterization of six novel proteins. Infect Immun (1998) 1.38
Latent tuberculosis: what the host "sees"? Immunol Res (2011) 1.35
Rv3615c is a highly immunodominant RD1 (Region of Difference 1)-dependent secreted antigen specific for Mycobacterium tuberculosis infection. Proc Natl Acad Sci U S A (2011) 1.35
Molecular basis of intrinsic macrolide resistance in clinical isolates of Mycobacterium fortuitum. J Antimicrob Chemother (2004) 1.35
Prevalence of latent tuberculosis infection among health care workers in a hospital for pulmonary diseases. J Occup Med Toxicol (2009) 1.34
Deletion of Mycobacterium tuberculosis sigma factor E results in delayed time to death with bacterial persistence in the lungs of aerosol-infected mice. Infect Immun (2003) 1.34
General secretion signal for the mycobacterial type VII secretion pathway. Proc Natl Acad Sci U S A (2012) 1.34
Risk of latent TB infection in individuals employed in the healthcare sector in Germany: a multicentre prevalence study. BMC Infect Dis (2010) 1.33
Biochemical and molecular analysis of phospholipase C and phospholipase D activity in mycobacteria. Infect Immun (1996) 1.33
Gamma interferon-based immunodiagnosis of tuberculosis: comparison between whole-blood and enzyme-linked immunospot methods. J Clin Microbiol (2004) 1.32
Zebrafish embryo screen for mycobacterial genes involved in the initiation of granuloma formation reveals a newly identified ESX-1 component. Dis Model Mech (2011) 1.32
Use of Mycobacterium tuberculosis complex-specific antigen cocktails for a skin test specific for tuberculosis. Infect Immun (1998) 1.32
Cell envelope protein PPE68 contributes to Mycobacterium tuberculosis RD1 immunogenicity independently of a 10-kilodalton culture filtrate protein and ESAT-6. Infect Immun (2004) 1.31
responses of mycobacterium tuberculosis to growth in the mouse lung. Infect Immun (2005) 1.31
Evaluation of T-cell responses to novel RD1- and RD2-encoded Mycobacterium tuberculosis gene products for specific detection of human tuberculosis infection. Infect Immun (2004) 1.30
EsaC substrate for the ESAT-6 secretion pathway and its role in persistent infections of Staphylococcus aureus. Mol Microbiol (2008) 1.30
Evaluation of the interferon-gamma release assay in healthcare workers. Int Arch Occup Environ Health (2007) 1.30
Differentiating host-associated variants of Mycobacterium avium by PCR for detection of large sequence polymorphisms. J Clin Microbiol (2006) 1.29
Pathogenesis, immunology, and diagnosis of latent Mycobacterium tuberculosis infection. Clin Dev Immunol (2010) 1.29
Mycobacterium tuberculosis H37Rv: Delta RD1 is more virulent than M. bovis bacille Calmette-Guérin in long-term murine infection. J Infect Dis (2004) 1.27
A point mutation in the mma3 gene is responsible for impaired methoxymycolic acid production in Mycobacterium bovis BCG strains obtained after 1927. J Bacteriol (2000) 1.26
Discrimination of Streptococcus pneumoniae from viridans group streptococci by genomic subtractive hybridization. J Clin Microbiol (2005) 1.25
A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res (1979) 214.95
High resolution two-dimensional electrophoresis of proteins. J Biol Chem (1975) 133.45
Colony hybridization: a method for the isolation of cloned DNAs that contain a specific gene. Proc Natl Acad Sci U S A (1975) 77.46
Unidirectional digestion with exonuclease III creates targeted breakpoints for DNA sequencing. Gene (1984) 56.23
Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. JAMA (1995) 15.26
Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA (1994) 14.96
New use of BCG for recombinant vaccines. Nature (1991) 14.40
Construction and expression of recombinant plasmids encoding type 1 or D-mannose-resistant pili from a urinary tract infection Escherichia coli isolate. Infect Immun (1981) 14.05
Isolation and characterization of efficient plasmid transformation mutants of Mycobacterium smegmatis. Mol Microbiol (1990) 13.71
Molecular biology of the LysR family of transcriptional regulators. Annu Rev Microbiol (1993) 10.30
The 65-kilodalton antigen of Mycobacterium tuberculosis. J Bacteriol (1987) 9.50
A large family of bacterial activator proteins. Proc Natl Acad Sci U S A (1988) 8.19
The Mycobacterium tuberculosis 65-kilodalton antigen is a heat shock protein which corresponds to common antigen and to the Escherichia coli GroEL protein. Infect Immun (1988) 5.03
Lysogeny and transformation in mycobacteria: stable expression of foreign genes. Proc Natl Acad Sci U S A (1988) 4.90
Effect of isoniazid on the in vivo mycolic acid synthesis, cell growth, and viability of Mycobacterium tuberculosis. Antimicrob Agents Chemother (1972) 4.64
Cloning of an M. tuberculosis DNA fragment associated with entry and survival inside cells. Science (1993) 4.57
A PhoP-repressed gene promotes Salmonella typhimurium invasion of epithelial cells. J Bacteriol (1993) 3.91
Recall of long-lived immunity to Mycobacterium tuberculosis infection in mice. J Immunol (1995) 3.85
Genomic subtraction for cloning DNA corresponding to deletion mutations. Proc Natl Acad Sci U S A (1990) 3.74
Stress proteins, infection, and immune surveillance. Cell (1989) 3.63
Virulence ranking of some Mycobacterium tuberculosis and Mycobacterium bovis strains according to their ability to multiply in the lungs, induce lung pathology, and cause mortality in mice. Infect Immun (1995) 3.31
Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine. J Exp Med (1993) 2.96
Extensive DNA sequence conservation throughout the Mycobacterium tuberculosis complex. J Clin Microbiol (1994) 2.89
Evidence for absence of the MPB64 gene in some substrains of Mycobacterium bovis BCG. Infect Immun (1993) 2.50
Human T-cell responses to secreted antigen fractions of Mycobacterium tuberculosis. Infect Immun (1995) 2.39
Gene expression in mycobacteria: transcriptional fusions based on xylE and analysis of the promoter region of the response regulator mtrA from Mycobacterium tuberculosis. Mol Microbiol (1994) 2.03
Heat shock proteins and antigens of Mycobacterium tuberculosis. Infect Immun (1991) 1.92
Separation of the mixture of trehalose 6,6'-dimycolates comprising the mycobacterial glycolipid fraction, "P3". Biochem Biophys Res Commun (1977) 1.82
Guinea pig cellular immune responses to proteins secreted by Mycobacterium tuberculosis. Infect Immun (1995) 1.72
Recombination between repeats in Escherichia coli by a recA-independent, proximity-sensitive mechanism. Mol Gen Genet (1994) 1.67
iciA, an Escherichia coli gene encoding a specific inhibitor of chromosomal initiation of replication in vitro. Proc Natl Acad Sci U S A (1991) 1.44
IciA protein, a specific inhibitor of initiation of Escherichia coli chromosomal replication. J Biol Chem (1992) 1.28
Opposed actions of regulatory proteins, DnaA and IciA, in opening the replication origin of Escherichia coli. J Biol Chem (1992) 1.26
The role of direct oligonucleotide repeats in gonococcal pilin gene variation. Mol Microbiol (1990) 1.19
Protein analysis using high-resolution two-dimensional polyacrylamide gel electrophoresis. Methods Enzymol (1990) 1.16
An amplifiable DNA region from the Mycoplasma hyorhinis genome. J Bacteriol (1994) 1.14
Repetitive sequences in the ribosomal intergenic spacer of Trypanosoma cruzi. Mol Biochem Parasitol (1993) 1.03
Multiple pathways of deletion formation in Escherichia coli. Mutat Res (1993) 1.00
[Nucleotide sequence and properties of an inverted repeating element of a Bordetella pertussis chromosome]. Genetika (1993) 0.98
Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature (2000) 32.30
Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein. Am J Hum Genet (2001) 4.97
Compensatory ahpC gene expression in isoniazid-resistant Mycobacterium tuberculosis. Science (1996) 4.51
Molecular cloning of invasion plasmid antigen (ipa) genes from Shigella flexneri: analysis of ipa gene products and genetic mapping. J Bacteriol (1987) 3.75
Structure of the fibre-forming protein pilin at 2.6 A resolution. Nature (1995) 3.70
The 16-kDa alpha-crystallin (Acr) protein of Mycobacterium tuberculosis is required for growth in macrophages. Proc Natl Acad Sci U S A (1998) 3.47
Disparate responses to oxidative stress in saprophytic and pathogenic mycobacteria. Proc Natl Acad Sci U S A (1995) 3.18
Staphylococcus aureus genetic loci impacting growth and survival in multiple infection environments. Mol Microbiol (1998) 3.04
Comparative antimycobacterial activities of rifampin, rifapentine, and KRM-1648 against a collection of rifampin-resistant Mycobacterium tuberculosis isolates with known rpoB mutations. Antimicrob Agents Chemother (1996) 2.75
Characterization of a Pseudomonas aeruginosa efflux pump contributing to aminoglycoside impermeability. Antimicrob Agents Chemother (1999) 2.74
Stringent chemical and thermal regulation of recombinant gene expression by vaccinia virus vectors in mammalian cells. Proc Natl Acad Sci U S A (1995) 2.45
A role for platelets and endothelial selectins in tumor necrosis factor-alpha-induced leukocyte recruitment in the brain microvasculature. Circ Res (2000) 2.41
Use of in vivo complementation in Mycobacterium tuberculosis to identify a genomic fragment associated with virulence. Infect Immun (1994) 2.26
Biochemical and genetic data suggest that InhA is not the primary target for activated isoniazid in Mycobacterium tuberculosis. J Infect Dis (1996) 2.13
Bioluminescence screening in vitro (Bio-Siv) assays for high-volume antimycobacterial drug discovery. Antimicrob Agents Chemother (1996) 1.94
The structure of human mitochondrial manganese superoxide dismutase reveals a novel tetrameric interface of two 4-helix bundles. Cell (1992) 1.91
Promising antituberculosis activity of the oxazolidinone PNU-100480 relative to that of linezolid in a murine model. Antimicrob Agents Chemother (2008) 1.89
Luciferase in vivo expression technology: use of recombinant mycobacterial reporter strains to evaluate antimycobacterial activity in mice. Antimicrob Agents Chemother (1996) 1.88
Molecular cloning and expression of Rickettsia tsutsugamushi genes for two major protein antigens in Escherichia coli. Infect Immun (1987) 1.87
Crystal structure and mutational analysis of the human CDK2 kinase complex with cell cycle-regulatory protein CksHs1. Cell (1996) 1.76
Systemic and mucosal immunity induced by BCG vector expressing outer-surface protein A of Borrelia burgdorferi. Nature (1994) 1.69
Protective humoral response against pneumococcal infection in mice elicited by recombinant bacille Calmette-Guérin vaccines expressing pneumococcal surface protein A. J Exp Med (1994) 1.55
Prefabrication of thin transferable axial-pattern skin flaps: an experimental study in rabbits. Br J Plast Surg (1990) 1.50
Visualization of Plasmodium falciparum-endothelium interactions in human microvasculature: mimicry of leukocyte recruitment. J Exp Med (2000) 1.49
Sequencing solution: use volunteer annotators organized via Internet. Nature (2000) 1.46
Antigenic and genetic relatedness of eight Rickettsia tsutsugamushi antigens. Infect Immun (1989) 1.45
Reporter gene technology to assess activity of antimycobacterial agents in macrophages. Antimicrob Agents Chemother (1996) 1.44
The association between alpha4-integrin, P-selectin, and E-selectin in an allergic model of inflammation. J Exp Med (1997) 1.34
A structural and immunological comparison of rickettsial HSP60 antigens with those of other species. Ann N Y Acad Sci (1990) 1.33
Identification of anti-alpha toxin monoclonal antibodies that reduce the severity of Staphylococcus aureus dermonecrosis and exhibit a correlation between affinity and potency. Clin Vaccine Immunol (2012) 1.33
Immunization with recombinant BCG-SIV elicits SIV-specific cytotoxic T lymphocytes in rhesus monkeys. J Immunol (1993) 1.30
Identification and characterization of the PutP proline permease that contributes to in vivo survival of Staphylococcus aureus in animal models. Infect Immun (1998) 1.29
Assessment of an anti-alpha-toxin monoclonal antibody for prevention and treatment of Staphylococcus aureus-induced pneumonia. Antimicrob Agents Chemother (2013) 1.25
Localization of binding sites within human von Willebrand factor for monomeric type III collagen. Biochemistry (1986) 1.25
Crystal structure of the human cell cycle protein CksHs1: single domain fold with similarity to kinase N-lobe domain. J Mol Biol (1995) 1.18
Impact of the high-affinity proline permease gene (putP) on the virulence of Staphylococcus aureus in experimental endocarditis. Infect Immun (1999) 1.17
Crystal structure of Y34F mutant human mitochondrial manganese superoxide dismutase and the functional role of tyrosine 34. Biochemistry (1998) 1.13
Human mitochondrial manganese superoxide dismutase polymorphic variant Ile58Thr reduces activity by destabilizing the tetrameric interface. Biochemistry (1996) 1.05
Neuronal nitric oxide synthase (NOS) regulates leukocyte-endothelial cell interactions in endothelial NOS deficient mice. Br J Pharmacol (2001) 1.04
Circulating human blood platelets retain appreciable amounts of poly (A)+ RNA. Biochem Biophys Res Commun (1989) 1.01
The functional paradox of CD43 in leukocyte recruitment: a study using CD43-deficient mice. J Exp Med (1998) 1.00
Rapid screening of natural products for antimycobacterial activity by using luciferase-expressing strains of Mycobacterium bovis BCG and Mycobacterium intracellulare. Antimicrob Agents Chemother (1997) 0.99
Novel phosphotransferase systems revealed by bacterial genome analysis: the complete repertoire of pts genes in Pseudomonas aeruginosa. J Mol Microbiol Biotechnol (1999) 0.99
Murine T-cell response to native and recombinant protein antigens of Rickettsia tsutsugamushi. Infect Immun (1993) 0.96
AhpC, oxidative stress and drug resistance in Mycobacterium tuberculosis. Biofactors (1999) 0.94
Probing the active site of human manganese superoxide dismutase: the role of glutamine 143. Biochemistry (1998) 0.94
Postischemic inflammation: a role for mast cells in intestine but not in skeletal muscle. Am J Physiol (1998) 0.91
Detection of Rickettsia tsutsugamushi by gene amplification using polymerase chain reaction techniques. Ann N Y Acad Sci (1990) 0.90
cDNA sequence for the alpha M subunit of the human neutrophil adherence receptor indicates homology to integrin alpha subunits. Proc Natl Acad Sci U S A (1989) 0.90
Transcriptional regulation of the leukocyte adherence protein beta subunit during human myeloid cell differentiation. J Biol Chem (1988) 0.89
Cerebral leucocyte infiltration in lupus-prone MRL/MpJ-fas lpr mice--roles of intercellular adhesion molecule-1 and P-selectin. Clin Exp Immunol (2006) 0.89
A mutation in the human cyclin-dependent kinase interacting protein, CksHs2, interferes with cyclin-dependent kinase binding and biological function, but preserves protein structure and assembly. J Mol Biol (1996) 0.86
Mechanisms of lymphocyte migration in autoimmune disease. Tissue Antigens (2005) 0.86
Overlapping roles for L-selectin and P-selectin in antigen-induced immune responses in the microvasculature. J Immunol (1999) 0.86
Alpha 4 integrin-dependent leukocyte recruitment does not require VCAM-1 in a chronic model of inflammation. J Immunol (2000) 0.85
Targeting leukocytes in immune glomerular diseases. Curr Med Chem (2008) 0.85
Microsurgical transfer of the greater omentum in the treatment of canine obstructive lymphoedema. Br J Plast Surg (1990) 0.85
Antimicrobial effects of novel siderophores linked to beta-lactam antibiotics. Bioorg Med Chem (2000) 0.85
Bacterial vaccine vectors and bacillus Calmette-Guérin. Clin Infect Dis (1995) 0.84
Hydrocephalus caused by tuberculous meningitis: clinical picture, CT findings and results of shunt surgery. Z Kinderchir (1983) 0.83
A morphological study of the long-term repair process in experimentally stretched but unruptured arteries and veins. Br J Plast Surg (1996) 0.82
Endogenous but not exogenous nitric oxide decreases TNF-alpha-induced leukocyte rolling. Am J Physiol (1997) 0.82
Development of BCG as a live recombinant vector system: potential use as an HIV vaccine. Biotechnol Ther (1991) 0.82
Old microbes with new faces: molecular biology and the design of new vaccines. Curr Opin Immunol (1992) 0.82
Molecular cloning and sequence analysis of a Rickettsia tsutsugamushi 22 kDa antigen containing B- and T-cell epitopes. Microb Pathog (1991) 0.81
The effect of immunosuppression on vascularised allografts. A preliminary report. J Bone Joint Surg Br (1989) 0.80
Long term results of submandibular gland transfer for the management of xerophthalmia. Br J Plast Surg (1991) 0.79
Efficacy and safety of live recombinant BCG vaccines. Dev Biol Stand (1995) 0.79
Orthotopic vascularized osteochondral allografts in an immunosuppressed rat model. J Reconstr Microsurg (1996) 0.78
Microvascular submandibular gland transfer for the management of xerophthalmia; an experimental study. Br J Plast Surg (1990) 0.78
Vascularized osteochondral allografts in an immunosuppressed rat model: graft modulation and host immune tolerance. Plast Reconstr Surg (1993) 0.78
Expression of the beta-subunit of the human leukocyte adherence receptor depends upon cell type and stage of differentiation. J Immunol (1988) 0.78
Mild hypothermia protects against ischaemia-reperfusion injury in rabbit skeletal muscle. Br J Plast Surg (1997) 0.78
Use of free interpositional vein grafts as pedicles for prefabrication of skin flaps. Microsurgery (1994) 0.77
The role of cellular adhesion molecules in surgery. Aust N Z J Surg (1995) 0.77
Ribosomal protein phosphorylation induced during Q fever or by lipopolysaccharide: in vitro translation is stimulated by infected liver ribosomes. Infect Immun (1985) 0.77
The effect of leuprolide acetate on steroidogenesis by granulosa and theca cells in vitro. J In Vitro Fert Embryo Transf (1991) 0.77
Expression of surface antigen and mRNA for the CD11c (alpha X, p150) subunit of the human leukocyte adherence receptor family in hematopoietic cells. Biochem Biophys Res Commun (1989) 0.77
Development and analysis of recombinant BCG vector systems. AIDS Res Hum Retroviruses (1992) 0.77
Effects of the endothelin receptor antagonist Bosentan on ischaemia/reperfusion injury in rat skeletal muscle. Eur J Pharmacol (2001) 0.76
Lymphocytes from systemic lupus erythematosus patients display increased spreading on VCAM-1, an effect associated with active renal involvement. Lupus (2012) 0.76
Nitric oxide synthase inhibitor, nitro-iminoethyl-L-ornithine, reduces ischemia-reperfusion injury in rabbit skeletal muscle. Microsurgery (1994) 0.76
Immunization against parasites: bridging the gap between attenuated and non-living vaccines. Behring Inst Mitt (1991) 0.76
Combined coumarin and omental transfer treatments for canine proximal obstructive lymphoedema. Int J Exp Pathol (1991) 0.75
Problems and successes in rural hospice development. Am J Hosp Care (1986) 0.75
Late occlusion of microvascular vein grafts in replantation. J Hand Surg Am (1998) 0.75
Fibroblast growth factor pretreatment of 1-mm PTFE grafts. Microsurgery (1996) 0.75
Meeting the problems through education and research. Harv Dent Alumni Bull (1968) 0.75
Immunohistochemical detection of strain-specific major histocompatibility complex class I antigens in paraffin-embedded rat osteochondral tissue. Histochem J (1993) 0.75
Effects of low dose intra-arterial monoclonal antibodies to ICAM-1 and CD11/CD18 on local and systemic consequences of ischaemia-reperfusion injury in skeletal muscle. Br J Plast Surg (1996) 0.75